ATE397098T1 - Verfahren zur diagnostik von eierstock endometriose - Google Patents

Verfahren zur diagnostik von eierstock endometriose

Info

Publication number
ATE397098T1
ATE397098T1 AT03795220T AT03795220T ATE397098T1 AT E397098 T1 ATE397098 T1 AT E397098T1 AT 03795220 T AT03795220 T AT 03795220T AT 03795220 T AT03795220 T AT 03795220T AT E397098 T1 ATE397098 T1 AT E397098T1
Authority
AT
Austria
Prior art keywords
ovarian endometriosis
diagnostic
methods
endometriosis
disclosed
Prior art date
Application number
AT03795220T
Other languages
German (de)
English (en)
Inventor
Yusuke Nakamura
Toyomasa Katagiri
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Application granted granted Critical
Publication of ATE397098T1 publication Critical patent/ATE397098T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/364Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03795220T 2002-08-30 2003-08-12 Verfahren zur diagnostik von eierstock endometriose ATE397098T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40736502P 2002-08-30 2002-08-30
US45092003P 2003-02-28 2003-02-28

Publications (1)

Publication Number Publication Date
ATE397098T1 true ATE397098T1 (de) 2008-06-15

Family

ID=31997699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03795220T ATE397098T1 (de) 2002-08-30 2003-08-12 Verfahren zur diagnostik von eierstock endometriose

Country Status (7)

Country Link
EP (1) EP1537243B1 (enExample)
JP (2) JP4401295B2 (enExample)
AT (1) ATE397098T1 (enExample)
AU (1) AU2003253440A1 (enExample)
CA (1) CA2497132A1 (enExample)
DE (1) DE60321356D1 (enExample)
WO (1) WO2004024952A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668371B1 (en) * 2003-09-24 2012-05-09 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis using tfpi-2 protein
BRPI0520012A2 (pt) * 2005-02-18 2009-04-14 Us Gov Health & Human Serv identificação de marcadores moleculares de diagnóstico para endometriose em linfócitos do sangue
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
EP2065707A1 (en) * 2007-11-28 2009-06-03 Laboratorios S.A.L.V.A.T., S.A. Detection of endometrial secretion markers for assesment of endometriosis
WO2010001585A1 (en) 2008-06-30 2010-01-07 Oncotherapy Science, Inc. Anti-cdh3 antibodies labeled with radioisotope label and uses thereof
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
JP5526378B2 (ja) * 2009-03-05 2014-06-18 国立大学法人山口大学 子宮頸癌の検出方法
WO2010124101A2 (en) 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
DK2519542T3 (en) 2009-12-28 2019-01-14 Onco Therapy Science Inc ANTI-CDH3 ANTIBODIES AND APPLICATIONS THEREOF.
JP5224308B2 (ja) * 2010-02-22 2013-07-03 公立大学法人横浜市立大学 卵巣明細胞腺癌に特異的に発現しているタンパク質とその応用
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
SG11201700303UA (en) * 2014-07-17 2017-02-27 Celmatix Inc Methods and systems for assessing infertility and related pathologies
JP6535357B2 (ja) * 2017-02-06 2019-06-26 国立研究開発法人農業・食品産業技術総合研究機構 非アルコール性脂肪肝治療用組成物、非アルコール性脂肪肝の治療剤の候補物質のスクリーニング方法及びdnaチップ
JP2021521803A (ja) * 2018-04-20 2021-08-30 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 子宮内膜症の治療のための組成物および方法
CN110408695A (zh) * 2019-04-05 2019-11-05 辽宁省肿瘤医院 子宫内膜异位症恶变相关卵巢癌诊断或预后标志物及应用
CN113994208A (zh) * 2019-04-26 2022-01-28 中外制药株式会社 子宫内膜异位症的诊断方法、疾病状态监测方法和试剂盒
JP2021175394A (ja) * 2020-04-24 2021-11-04 花王株式会社 月経周期マーカー
WO2024223379A1 (en) * 2023-04-27 2024-10-31 Scailyte Ag Biomarkers for the diagnosis of diseases or disorders of the female reproductive tract
CN119769990B (zh) * 2024-12-26 2025-09-09 大连医科大学附属第二医院 子宫内膜异位症的检测系统和治疗剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828003A3 (en) * 1996-09-06 2003-01-15 SmithKline Beecham plc Human serine protease
GB9806104D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
ES2272061T5 (es) * 1998-04-15 2012-02-24 Merck Serono Biodevelopment Secuencia genómica de la proteína activadora de 5-lipoxigenasa (flap), marcadores polimórficos de la misma y métodos para la detección de asma.
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU2001266787A1 (en) * 2000-06-07 2002-01-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2002000939A2 (en) * 2000-06-28 2002-01-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
EP1202065A1 (en) * 2000-10-25 2002-05-02 Aventis Pharma S.A. Net, a transcription factor of the TCF family, as regulator of angiogenic expression.

Also Published As

Publication number Publication date
AU2003253440A8 (en) 2004-04-30
AU2003253440A1 (en) 2004-04-30
EP1537243A1 (en) 2005-06-08
JP2010029189A (ja) 2010-02-12
WO2004024952A1 (en) 2004-03-25
JP4401295B2 (ja) 2010-01-20
DE60321356D1 (de) 2008-07-10
JP4942052B2 (ja) 2012-05-30
EP1537243B1 (en) 2008-05-28
CA2497132A1 (en) 2004-03-25
JP2005537027A (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
ATE397098T1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE496142T1 (de) Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
EP1788938A4 (en) SYSTEM, SOFTWARE AND METHOD FOR DETECTING RESPIRATORY DISORDERS DURING SLEEP USING AN ELECTROCARDIOGRAM
EP1697024A4 (en) METHODS AND APPARATUS FOR IMPROVING ION-BASED SAMPLING DETECTION USING PRE-SEPARATION AND AMPLIFICATION
DE60223635D1 (de) Reagenzien, Verfahren und Vorrichtungen zum Nachweis von Analyten
DE602004000494D1 (de) Vorrichtung und Verfahren zum Lesen der Seriennummern von Banknoten
ATE381552T1 (de) Derivate von 1-piperazin- und 1- homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
ATA8612001A (de) Verfahren zum testen von software
DE60309299D1 (de) System und Verfahren zur Ablaufverfolgung von Banknoten
DE602004023824D1 (de) Verfahren zum direkten nachweis einzelner methotrexatmetabolite
ATE426858T1 (de) System und verfahren zum erkennen von bísartigem code
DE602004021994D1 (de) Vorrichtung, Verfahren und Software zur Verfolgung von Gegenständen
DE60008712D1 (de) Verfahren zur detektion von endometriosis
DE60235211D1 (de) Verfahren zum Vorlöschen von Rauschen eines Bildes.
DE602004022105D1 (de) Vorrichtung, Verfahren und Software zur Verfolgung von Gegenständen
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE602005026249D1 (de) Vorrichtung, Verfahren und Computerprogrammprodukt zur Schätzung von Sicherheitsinformationen
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602005000975D1 (de) Verfahren zum Erkennen von Gegensteuern
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
DE502004012314D1 (de) Verfahren zum reaktiv-färben von leder, sowie farbstoffe und deren verwendung
ATE456666T1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE60130970D1 (de) Reagenziensatz zur detektion von mikroorganismen, vorrichtung zur quantifizierungvon mikroorganismen und verfahren zur quantifizierung von mikroorganismen
ATE426039T1 (de) Verfahren fur den nachweis von streptococcus agalactiae mittels alpha-glucosidase-aktivitat
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties